Bicarbion®'s patented capsule technology delivers bicarbonate directly to the small intestine, ensuring that the active ingredient passes through the stomach unharmed and is absorbed in a more predictable manner.

A scientifically proven solution to aid digestion and enhance athletic performance.

What are the most important expectations of health-conscious and active people when it comes to bicarbonate?

• They want the active ingredient to be absorbed and not lost in the acidic environment of the stomach.
• Predictable and measurable effects are important to them, not just theoretical promises.
• They are looking for a solution that is effective without placing unnecessary strain on the body.
• They expect scientific validation and clinical backing.
• They want a product that is safe to use in the long term and of reliable quality.

Traditional bicarbonate preparations cannot guarantee this.

• Bicarbonate taken orally is significantly neutralized in the acidic environment of the stomach before it can be utilized.
• As a result, the active ingredient does not reach the small intestine, where most of the absorption would take place, in sufficient concentration.
• The rate of absorption is often unpredictable and varies from person to person.
• Many preparations do not have a genuine, targeted coating technology.
• There is currently no similar product on the market that has been proven to dissolve in the small intestine.

Bicarbion®'s patented capsule technology provides the answer to this problem.

• Bicarbion's special coating resists the acidic environment of the stomach and the alkaline effect of bicarbonate, allowing the active ingredient to pass through the stomach unharmed.
• The capsule dissolves in the small intestine after approximately 35 minutes, where the bicarbonate ion reaches its most important site of action directly.
• This targeted release allows the active ingredient to be utilized in greater proportions and more predictably than with traditional forms.
• Clinical dose trials have been completed, and the results have confirmed that the capsule passes through the stomach and dissolves in the small intestine.
• The purpose of the blood tests currently underway is to measure the extent to which the bicarbonate level in the blood rises after ingestion.
• Serial production of the product has begun, and the manufacturing plant is capable of producing hundreds of thousands of capsules per day.
• International distribution agreements are being prepared in Europe and other regions, confirming the intention to enter the global market.
• Therapeutic areas:
  • Health maintenance: natural protection against acidosis.
  • Treatment of health problems: studies are underway on the effectiveness of Bicarbion in treating reflux, Crohn's disease, digestive disorders, inflammation, diabetes, and obesity.
  • Enhancing athletic performance: 17-25% increase in anaerobic activity and 8-15% increase in aerobic activity, as well as faster recovery and reduced acidosis.

Become our co-owner or distributor and join Bicarbion®'s international expansion and share in the growth.

• Learn about our patented technology and product portfolio!

• Let's move forward with a co-ownership, distribution, or manufacturing partnership!

• Join us in the next phase of growth as a strategic partner!

Bicarbion® offers long-term structural advantages in the market.

• Targeted absorption allows for more precise and predictable effects.
• The patented coating technology represents a barrier to entry for competitors.
• Production at the raw material and finished product levels allows for flexible business models.
• Entering the international market offers significant scaling potential in the future, with distribution possible under both own and partner brands.

Enter a new era of targeted bicarbonate technology now!

To join as a co-owner, please contact us at: [email protected]